Last reviewed · How we verify

Actomol (MEBANAZINE)

FDA-approved withdrawn Small molecule Quality 19/100

At a glance

Generic nameMEBANAZINE
Drug classMonoamine Oxidase Inhibitors
TargetAmine oxidase [flavin-containing] A
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: